A new generation of drugs is revolutionizing the treatment of obesity and astonishing researchers with their potency. The drug semaglutide, for example, enabled one-third of clinical-trial participants to shed at least 20% of their body weight1. Tirzepatide, a competing therapy, achieved similar results in more than half of study participants2.
